G. Gosset et al. / Bioorg. Med. Chem. 19 (2011) 2218–2230
2227
in toluene (5 mL) for 4–6 h at room temperature (conversion was
CH
2 3
CH ), 1.66–1.92 (m, 4H, 3-H, 4-H, NH), 2.21–2.36 (m, 1H, 3-
3
1
checked by TLC or P NMR), the mixture was poured into 30 mL
water, slowly acidified to pH 3 with 11 N HCl then quickly ex-
tracted with tert-butyl methyl ether (TBME) (3 Â 20 mL). The aque-
ous phase was basified to pH 9–10 with NaOH pellets then
H), 2.85–2.97 (m, 1H, 5-H), 3.05–3.13 (m, 1H, 5-H), 4.10–4.23 (m,
1
3
4H, OCH
22.52 (CH
(d, J = 4.5 Hz, 4-C), 34.80 (d, J = 3.8 Hz, 3-C), 37.55 (d, J = 5.3 Hz,
CEt ), 47.36 (d, J = 6.8 Hz, 5-C), 60.44 (d, J = 163.1 Hz, 2-C), 73.69
(d, J = 7.5 Hz, OCH ), 73.79 (d, J = 7.5 Hz, OCH ); Anal. Calcd for
2
); C NMR (CDCl
3 2 3 2 3
) d 7.02 (CH CH ), 7.11 (CH CH ),
2
CH ), 22.99 (CH CH
3
2
3
), 24.32 (d, J = 7.5 Hz, 2-Me), 25.88
extracted with CH
were dried over MgSO
crude aminophosphonates 3a–3e as white powders which were
then purified by SiO column chromatography with eluent
CH Cl /EtOH 8/1.
2
Cl
2
(4 Â 20 mL). The combined organic phases
2
4
, filtered and roto-evaporated to give the
2
2
C
12
H24NO
3
P: C, 55.17; H, 9.20; N, 5.36. Found: C, 55.25; H, 9.56;
2
N, 5.28.
2
2
4
.2.2.6.
2-Methyl-2-(4,4,6,6-tetramethyl-2-oxo-1,3,2-diox-
4
.2.2.1. 2-Methyl-2-(2-oxo-1,3,2-dioxaphosphinan-2-yl)pyrroli-
aphosphinan-2-yl)pyrrolidine (3e). White crystals. Yield: 63%.
31
31
1
dine (3a). White crystals. Yield: 52%. Mp 79 °C. P NMR (CDCl
3
) d
) d 1.39 (d, J = 15 Hz, 3H, 2-Me), 1.61–2.10
, 3-H, 4-H, NH), 2.21–2.33 (m, 1H, 3-H),
.85–2.93 (m, 1H, 5-H), 3.05–3.11 (m, 1H, 5-H), 4.42–4.54 (m,
H, OCH –CH –CH ) d 24.24 (d, J = 6.8 Hz, 2-
O); 13C NMR (CDCl
–CH –CH ),
4.77 (d, J = 3.8 Hz, 3-C), 47.35 (d, J = 3.8 Hz, 5-C), 60.38 (d,
J = 163.8 Hz, 2-C), 67.30 (d, J = 8.3 Hz, CH –CH –CH ), 67.40 (d,
J = 8.3 Hz, CH –CH –CH ); Anal. Calcd for C P: C, 46.83; H,
.86; N, 6.83. Found: C, 46.33; H, 7.83; N, 6.86.
Mp 93 °C. P NMR (CDCl
J = 18 Hz, 3H, 2-Me), 1.44 (3H, CCH
CCH ), 1.70–1.90 (m, 4H, 3-H, 4-H, NH), 1.97–2.13 (dd, J = 15 Hz,
J = 6 Hz, 2H, C(CH CH C(CH ), 2.21–2.38 (m, 1H, 3-H), 2.96–
3.03 (m, 2H, 5-H); C NMR (CDCl ) d 24.30 (d, J = 7.5 Hz, 2-Me),
25.64 (d, J = 5.3 Hz, 4-C), 30.89–31.19–31.30–31.37 (C(CH
CH C(CH ), 34.63 (d, J = 3.8 Hz, 3-C), 47.05 (d, J = 6.8 Hz, 2H, 5-C),
47.32 (d, J = 8.3 Hz, C(CH CH C(CH ), 59.33 (d, J = 163.1 Hz, 2-
C), 79.73 (d, J = 6.8 Hz, OCMe ), 79.82 (d, J = 6.8 Hz, OCMe ); Anal.
Calcd for C12 P: C, 55.16; H, 9.26; N, 5.36. Found: C, 54.77;
H, 9.28; N, 5.31.
3
) d 25.32; H NMR (CDCl
3
) d 1.33 (d,
1
2
6.00; H NMR (CDCl
3
3
), 1.45 (3H, CCH
3
), 1.59 (6H,
(
m, 6H, CH –CH –CH
2
2
2
3
2
4
3
)
2
2
3 2
)
13
2
2
2
3
3
Me), 25.90 (d, J = 3.8 Hz, 4-C), 26.76 (d, J = 8.3 Hz, CH
2
2
2
3 2
) -
3
2
3
2
2
2
3
)
2
2
3 2
)
2
2
2
8
H20NO
3
2
2
7
H24NO
3
4
.2.2.2. trans-2-Methyl-2-(5-methyl-2-oxo-1,3,2-dioxaphosph-
inan-2-yl)pyrrolidine (trans-3b). White crystals. Yield: 55%. Mp
4.2.3. Synthesis of nitrones 4a–4e
To aminophosphonates 3a–3e (24.5 mmol) in water (50 mL)
was added at 0 °C during 48 h under stirring, 30%
(51.45 mmol, 4.4 mL) in presence of a catalytic amount of Na WO
2
(403 mg, 1.22 mmol). At the end of the addition, aqueous phase
3
1
1
9
3
1 °C. P NMR (CDCl
H, CHCH ), 1.40 (d, J = 15 Hz, 3H, 2-Me), 1.62–1.90 (m, 4H, 3-H, 4-
), 2.79–
.87 (m, 1H, 5-H), 3.08–3.15 (m, 1H, 5-H), 4.16–4.38 (m, 4H,
3
) d 23.25; H NMR (CDCl
3
) d 0.88 (d, J = 6 Hz,
3
H
2
O
2
H, NH), 2.22–2.32 (m, 1H, 3-H), 2.40–2.50 (m, 1H, CHCH
2
OCH
3
4
1
3
2
CHCH
3
CH
2
O); C NMR (CDCl
3
) d 11.95 (CHCH
3
), 24.31 (d,
was saturated with NaCl, extracted first with TBME (2 Â 50 mL)
J = 6.8 Hz, 2-Me), 25.98 (d, J = 3,8 Hz, 4-C), 30.96 (d, J = 9 Hz,
CHCH ), 34.97 (d, J = 2.8 Hz, 3-C), 47.45 (d, J = 6.8 Hz, 5-C), 61.31
d, J = 166.8 Hz, 2-C), 73.82 (d, J = 8.3 Hz, OCH ), 73.96 (d,
J = 7.5 Hz, OCH ); Anal. Calcd for C P: C, 49.31; H, 8.28; N,
.39. Found: C, 49.33; H, 8.52; N, 6.36.
then with CHCl
3
(4 Â 50 mL). The combined chloroform phases
3
were dried over MgSO
to lead to crude nitrones 4a–4e that were first purified by SiO
umn chromatography with eluent CH Cl /EtOH 7/1 then recrystal-
lized in TBME/CH Cl These separation and purification
4
, filtered and concentrated under vacuum
(
2
2
col-
2
9
H18NO
3
2
2
6
2
2
.
procedures allowed to separate cis/trans diastereoisomers of 4b,
the stereochemistry of which was determined by X-ray diffraction
(see Section 2).
4
.2.2.3.
cis-2-Methyl-2-(5-methyl-2-oxo-1,3,2-dioxaphosph-
3
1
inan-2-yl)pyrrolidine (cis-3b). Yellow oil. Yield: 16%. P NMR
1
(
CDCl
3
) d 27.7; H NMR (CDCl
.40 (d, J = 18 Hz, 3H, 2-Me), 1.60–1.93 (m, 4H, 3-H, 4-H, NH),
.22–2.38 (m, 2H, 3-H, CHMe), 2.94–3.01 (m, 1H, 5-H), 3.03–3.12
CHMeCH
O); 13C NMR (CDCl
), 23.90 (d, J = 7.5 Hz, 2-Me), 25.56 (d, J = 5.3 Hz, 4-
), 34.57 (d, J = 3.8 Hz, 3-C), 47.10 (d,
J = 6.8 Hz, 2H, 5-C), 59.99 (d, J = 163 Hz, 2-C), 70.80 (d, J = 6.8 Hz,
OC(CH ), 70.99 (d, J = 6.8 Hz, OC(CH ); Anal. Calcd for
3 3
) d 0.90 (d, J = 6 Hz, 3H, CHCH ),
1
2
4.2.3.1.
2-Methyl-2-(2-oxo-1,3,2-dioxaphosphinan-2-yl)-3,4-
dihydro-2H-pyrrole 1-oxide [CyDEPMPO (4a)]. Yellow crystals.
31
1
(
m, 1H, 5-H), 4.12–4.28 (m, 4H, OCH
2
2
3
)
Yield: 90%. Mp 115 °C; P NMR (CDCl
d 1.73 (d, J = 15 Hz, 3H, 2-Me), 1.82–1.89 (m, 2H, CH
2.24–2.35 (m, 1H, 3-H), 2.56–2.80 (m, 2H, 4-H), 2.90–3.03 (m,
1H, 3-H), 4.33–4.54 (m, 3H, O–CH –CH –CH –O), 4.98–5.07 (m,
–O), 6.92 (q, J = 3 Hz et J = 6 Hz, 1H, 5-H);
) d 20.61 (d, J = 1 Hz, 2-Me), 25.68 (d, J = 1 Hz, 4-
–CH –CH ), 30.91 (3-C), 68.48 (d,
), 69.95 (d, J = 8.25 Hz, CH –CH –CH ),
75.37 (d, J = 152.5 Hz, 2-C), 135.04 (d, J = 7.5 Hz, 5-C); Anal. Calcd
for C P: C, 43.84; H, 6.44; N, 6.39. Found: C, 43.83, H,
6.60; N, 6.38.
3
) d 14.72; H NMR (CDCl
3
)
d 11.99 (CHCH
3
2
–CH –CH ),
2
2
C), 30.91 (d, J = 9 Hz, CHCH
3
2
2
2
3
)
2
3
)
2
1H, O–CH
C NMR (CDCl
2
–CH
2
3
–CH
2
1
3
C
9
H18NO
3
P: C, 49.31; H, 8.28; N, 6.39. Found: C, 48.93; H, 8.65;
N, 5.55.
C), 26.48 (d, J = 3 Hz, CH
J = 6.7 Hz, CH –CH –CH
2
2
2
2
2
2
2
2
2
4
.2.2.4.
2-Methyl-2-(5,5-dimethyl-2-oxo-1,3,2-dioxaphosph-
inan-2-yl)pyrrolidine (3c). White crystals. Yield: 80%. Mp
8 4
H14NO
3
1
) d 26.43; 1H NMR (CDCl
) d 1.04 (3H,
3 3
1
10 °C. P NMR (CDCl
CCH ), 1.06 (3H, CCH ), 1.41 (d, J = 15 Hz, 3H, 2-Me), 1.61–1.94
m, 4H, 3-H, 4-H, NH), 2.26–2.38 (m, 1H, 3-H), 2.88–2.96 (m, 1H,
3
3
(
4.2.3.2. trans-2-Methyl-2-(5-methyl-2-oxo-1,3,2-dioxaphosph-
inan-2-yl)-3,4-dihydro-2H-pyrrole 1-oxide[trans-MeCyDEPMPO
1
3
5
(
2
-H), 3.06–3.13 (m, 1H, 5-H), 3.98–4.19 (m, 4H, OCH
CDCl ) d 21.55 (CCH ), 21.72 (CCH ), 24.30 (d, J = 6.8 Hz, 2-Me),
5.80 (d, J = 4.5 Hz, 4-C), 32.75 (d, J = 6.8 Hz, C(CH ), 34.80 (d,
2
); C NMR
31
3
3
3
(trans-4b)]. Yellow crystals. Yield: 81%. Mp 120 °C. P NMR
1
3
)
2
(CDCl
1.74 (d, J = 15 Hz, 3H, 2-CH
(m, 1H, CH–CH ), 2.65–2.76 (m, 2H, 4-H), 2.80–3.05 (m, 1H, 3-H),
4.07–4,14 (m, 1H, OCH ), 4.15–4.30 (m, 2H, OCH ), 4.70–4.78 (m,
1H, OCH ), 6.91 (q, J = 3 Hz et J = 6 Hz, 1H, 5-H); C NMR (CDCl
d 10.89 (CHCH ), 20.65 (d, J = 15 Hz, 2-Me), 25.66 (4-C), 30.84 (3-
C) 30.95 (d, J = 10 Hz, CHCH ), 73.52 (d, J = 6.5 Hz, OCH ), 75.38
(d, J = 150 Hz, 2-C), 75.45 (d, J = 7.5 Hz, OCH ), 134,91 (d,
J = 9.0 Hz, 5-C); Anal. Calcd for C P: C, 46.35; H, 6.92; N,
6.01. Found: C, 46.13; H, 7.13; N, 5.99.
3
) d 13.59; H NMR (CDCl
3 3
) d 0.81 (d, J = 9 Hz, 3H, CH–CH ),
J = 3.8 Hz, 3-C), 47.35 (d, J = 6.8 Hz, 5-C), 60.26 (d, J = 163 Hz, 2-
C), 76.03 (d, J = 7.5 Hz, OCH ), 76.21 (d, J = 7.5 Hz, OCH ); Anal.
Calcd for C10 P: C, 43.52; H, 8.35; N, 7.25. Found: C, 42.37;
H, 8.21; N, 7.39.
3
), 2.16–2.50 (m, 1H, 3-H), 2.48–2.60
2
2
3
H20NO
3
2
2
1
3
2
3
)
3
4
2
.2.2.5. 2-Methyl-2-(5,5-diethyl-2-oxo-1,3,2-dioxaphosphinan-
,
3
2
3
1
-yl)pyrrolidine (3d). White crystals. Yield: 58%. Mp 107 °C.
) d 27.10; 1H NMR (CDCl
) d 0.84 (t, J = 9 Hz, 6H,
), 1.40 (d, J = 15 Hz, 3H, 2-Me), 1.46 (q, J = 9 Hz, 4H,
P
2
NMR (CDCl
CH CH
3
3
9 4
H16NO
2
3